Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

Fondation Hôpital Saint-Joseph87 enrolled

Overview

Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anal Carcinoma

Interventions

MRI sequenceDIAGNOSTIC_TEST

several MRI sequence before and after contrast product injection.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient with anal canal cell carcinoma histologically proved * patient with initial MRI and follow up MRI in Hospital St Joseph's radiology yard. * patient for whom a radio chemotherapy treatment decision was taken. Exclusion Criteria: * patients with already metastatic lesions

Locations (1)

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, France

Outcomes

Primary Outcomes

Distance with regard to the anal margin

tumor position

Time frame: maximum of 6 years after the initial MRI

initial tumor size

Maximal tumoral size in the cranio-caudal plan in cm

Time frame: maximum of 6 years after the initial MRI

presence of nodal status

presence of nodal status in inguinal region

Time frame: maximum of 6 years after the initial MRI

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.